Skip to main content

Table 1 Demographic and clinical characteristics of the study population before the use of anti-TB therapy

From: Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time

 

DS-TB (N = 13)

DR-TB (N = 7)

p

Age (years)

33 (25–44)

56 (27–67)

0.057

Male, n(%)

6 (46%)

4 (57%)

0.500

Diabetes, n(%)

5 (48%)

4 (57%)

0.370

Glucose, mg/dL

106 (94–151)

132 (93–146)

0.641

Sputum culture

   

 Mycobacterium tuberculosis

12 (92%)

6 (86%)

 Mycobacterium bovis

1 (8%)

1 (14%)

  1. Data is represented with median and interquartile range (IQR, 25–75). U Mann Whitney and one-sided Fisher’s exact test were used
  2. DS-TB drug-susceptible tuberculosis, DR-TB drug-resistant tuberculosis